Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
90,710,688
-
Share change
-
-694,226
-
Total reported value
-
$313,029,185
-
Put/Call ratio
-
198%
-
Price per share
-
$3.52
-
Number of holders
-
134
-
Value change
-
-$52,836,088
-
Number of buys
-
64
-
Number of sells
-
80
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q3 2015
As of 30 Sep 2015,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
134 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,710,688 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, STATE STREET CORP, FRANKLIN RESOURCES INC, ABRAMS CAPITAL MANAGEMENT, L.P., FMR LLC, OAK RIDGE INVESTMENTS LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and Apex Capital Management.
This page lists
134
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.